Computer-Aided Design of Nanoceria Structures as Enzyme Mimetic Agents

The Role of Bodily Electrolytes on Maximizing Their Activity

Marco Molinari, Adam Symington, Dean C. Sayle, Tamilselvan Sakthivel, Sudipta Seal, Stephen Parker

Research output: Contribution to journalArticle

69 Downloads (Pure)

Abstract

Nanoceria, typically used for "clean-air" catalytic converter technologies because of its ability to capture, store, and release oxygen, is the same material that has the potential to be used in nanomedicine. Specifically, nanoceria can be used to control oxygen content in cellular environments; as a "nanozyme", nanoceria mimics enzymes by acting as an antioxidant agent. The computational design procedures for predicting active materials for catalytic converters can therefore be used to design active ceria nanozymes. Crucially, the ceria nanomedicine is not a molecule; rather, it is a crystal and exploits its unique crystal properties. Here, we use ab initio and classical computer modeling, together with the experiment, to design structures for nanoceria that maximize its nanozymetic activity. We predict that the optimum nanoparticle shape is either a (truncated) polyhedral or a nanocube to expose (active) CeO 2{100} surfaces. It should also contain oxygen vacancies and surface hydroxyl species. We also show that the surface structures strongly affect the biological activity of nanoceria. Analogous to catalyst poisoning, phosphorus "poisoning", the interaction of nanoceria with phosphate, a common bodily electrolyte, emanates from phosphate ions binding strongly to CeO 2{100} surfaces, inhibiting oxygen capture and release and hence its ability to act as a nanozyme. Conversely, the phosphate interaction with {111} surfaces is weak, and therefore, these surfaces protect the nanozyme against poisoning. The atom-level understanding presented here also illuminates catalytic processes and poisoning in "clean-air" or fuel-cell technologies because the mechanism underpinning and exploited in each technology, oxygen capture, storage, and release, is identical.

Original languageEnglish
Pages (from-to)1098-1106
Number of pages9
JournalACS Applied Biomaterials
Volume2
Issue number3
Early online date23 Jan 2019
DOIs
Publication statusPublished - 18 Mar 2019

Keywords

  • antioxidant
  • cerium oxide nanoparticles
  • density functional theory
  • enzyme mimetic activity
  • molecular dynamics
  • oxidative stress
  • phosphate
  • prescription for therapeutic activity

ASJC Scopus subject areas

  • Biomaterials
  • Chemistry(all)
  • Biomedical Engineering
  • Biochemistry, medical

Cite this

Computer-Aided Design of Nanoceria Structures as Enzyme Mimetic Agents : The Role of Bodily Electrolytes on Maximizing Their Activity. / Molinari, Marco; Symington, Adam; Sayle, Dean C.; Sakthivel, Tamilselvan; Seal, Sudipta; Parker, Stephen.

In: ACS Applied Biomaterials, Vol. 2, No. 3, 18.03.2019, p. 1098-1106.

Research output: Contribution to journalArticle

@article{d5d59051b4f4460ca3ab4a5a4c0de793,
title = "Computer-Aided Design of Nanoceria Structures as Enzyme Mimetic Agents: The Role of Bodily Electrolytes on Maximizing Their Activity",
abstract = "Nanoceria, typically used for {"}clean-air{"} catalytic converter technologies because of its ability to capture, store, and release oxygen, is the same material that has the potential to be used in nanomedicine. Specifically, nanoceria can be used to control oxygen content in cellular environments; as a {"}nanozyme{"}, nanoceria mimics enzymes by acting as an antioxidant agent. The computational design procedures for predicting active materials for catalytic converters can therefore be used to design active ceria nanozymes. Crucially, the ceria nanomedicine is not a molecule; rather, it is a crystal and exploits its unique crystal properties. Here, we use ab initio and classical computer modeling, together with the experiment, to design structures for nanoceria that maximize its nanozymetic activity. We predict that the optimum nanoparticle shape is either a (truncated) polyhedral or a nanocube to expose (active) CeO 2{100} surfaces. It should also contain oxygen vacancies and surface hydroxyl species. We also show that the surface structures strongly affect the biological activity of nanoceria. Analogous to catalyst poisoning, phosphorus {"}poisoning{"}, the interaction of nanoceria with phosphate, a common bodily electrolyte, emanates from phosphate ions binding strongly to CeO 2{100} surfaces, inhibiting oxygen capture and release and hence its ability to act as a nanozyme. Conversely, the phosphate interaction with {111} surfaces is weak, and therefore, these surfaces protect the nanozyme against poisoning. The atom-level understanding presented here also illuminates catalytic processes and poisoning in {"}clean-air{"} or fuel-cell technologies because the mechanism underpinning and exploited in each technology, oxygen capture, storage, and release, is identical.",
keywords = "antioxidant, cerium oxide nanoparticles, density functional theory, enzyme mimetic activity, molecular dynamics, oxidative stress, phosphate, prescription for therapeutic activity",
author = "Marco Molinari and Adam Symington and Sayle, {Dean C.} and Tamilselvan Sakthivel and Sudipta Seal and Stephen Parker",
year = "2019",
month = "3",
day = "18",
doi = "10.1021/acsabm.8b00709",
language = "English",
volume = "2",
pages = "1098--1106",
journal = "ACS Applied Biomaterials",
issn = "2576-6422",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Computer-Aided Design of Nanoceria Structures as Enzyme Mimetic Agents

T2 - The Role of Bodily Electrolytes on Maximizing Their Activity

AU - Molinari, Marco

AU - Symington, Adam

AU - Sayle, Dean C.

AU - Sakthivel, Tamilselvan

AU - Seal, Sudipta

AU - Parker, Stephen

PY - 2019/3/18

Y1 - 2019/3/18

N2 - Nanoceria, typically used for "clean-air" catalytic converter technologies because of its ability to capture, store, and release oxygen, is the same material that has the potential to be used in nanomedicine. Specifically, nanoceria can be used to control oxygen content in cellular environments; as a "nanozyme", nanoceria mimics enzymes by acting as an antioxidant agent. The computational design procedures for predicting active materials for catalytic converters can therefore be used to design active ceria nanozymes. Crucially, the ceria nanomedicine is not a molecule; rather, it is a crystal and exploits its unique crystal properties. Here, we use ab initio and classical computer modeling, together with the experiment, to design structures for nanoceria that maximize its nanozymetic activity. We predict that the optimum nanoparticle shape is either a (truncated) polyhedral or a nanocube to expose (active) CeO 2{100} surfaces. It should also contain oxygen vacancies and surface hydroxyl species. We also show that the surface structures strongly affect the biological activity of nanoceria. Analogous to catalyst poisoning, phosphorus "poisoning", the interaction of nanoceria with phosphate, a common bodily electrolyte, emanates from phosphate ions binding strongly to CeO 2{100} surfaces, inhibiting oxygen capture and release and hence its ability to act as a nanozyme. Conversely, the phosphate interaction with {111} surfaces is weak, and therefore, these surfaces protect the nanozyme against poisoning. The atom-level understanding presented here also illuminates catalytic processes and poisoning in "clean-air" or fuel-cell technologies because the mechanism underpinning and exploited in each technology, oxygen capture, storage, and release, is identical.

AB - Nanoceria, typically used for "clean-air" catalytic converter technologies because of its ability to capture, store, and release oxygen, is the same material that has the potential to be used in nanomedicine. Specifically, nanoceria can be used to control oxygen content in cellular environments; as a "nanozyme", nanoceria mimics enzymes by acting as an antioxidant agent. The computational design procedures for predicting active materials for catalytic converters can therefore be used to design active ceria nanozymes. Crucially, the ceria nanomedicine is not a molecule; rather, it is a crystal and exploits its unique crystal properties. Here, we use ab initio and classical computer modeling, together with the experiment, to design structures for nanoceria that maximize its nanozymetic activity. We predict that the optimum nanoparticle shape is either a (truncated) polyhedral or a nanocube to expose (active) CeO 2{100} surfaces. It should also contain oxygen vacancies and surface hydroxyl species. We also show that the surface structures strongly affect the biological activity of nanoceria. Analogous to catalyst poisoning, phosphorus "poisoning", the interaction of nanoceria with phosphate, a common bodily electrolyte, emanates from phosphate ions binding strongly to CeO 2{100} surfaces, inhibiting oxygen capture and release and hence its ability to act as a nanozyme. Conversely, the phosphate interaction with {111} surfaces is weak, and therefore, these surfaces protect the nanozyme against poisoning. The atom-level understanding presented here also illuminates catalytic processes and poisoning in "clean-air" or fuel-cell technologies because the mechanism underpinning and exploited in each technology, oxygen capture, storage, and release, is identical.

KW - antioxidant

KW - cerium oxide nanoparticles

KW - density functional theory

KW - enzyme mimetic activity

KW - molecular dynamics

KW - oxidative stress

KW - phosphate

KW - prescription for therapeutic activity

UR - http://www.scopus.com/inward/record.url?scp=85072837030&partnerID=8YFLogxK

U2 - 10.1021/acsabm.8b00709

DO - 10.1021/acsabm.8b00709

M3 - Article

VL - 2

SP - 1098

EP - 1106

JO - ACS Applied Biomaterials

JF - ACS Applied Biomaterials

SN - 2576-6422

IS - 3

ER -